Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diego Bagnasco

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Current Opinion in Allergy and Clinical Immunology|June 15, 2021
Real-life studies in allergen immunotherapyGiovanni Passalacqua, Diego Bagnasco
Biomedicines|February 27, 2026
New Insights in Respiratory DiseasesDiego Bagnasco, Benedetta Bondi
Frontiers in Immunology|January 16, 2023
Editorial: Innate immunity and severe asthma: From microbiome to target therapyDiego Bagnasco, Marco Caminati
Allergy|July 19, 2019
Severe asthma, biologicals, and auto-injection: Yes, no, may be!Carlo Lombardi, Giovanni Passalacqua, Diego Bagnasco
Current Opinion in Allergy and Clinical Immunology|November 6, 2019
Biologicals for severe asthma: what we can learn from real-life experiences?Diego Bagnasco, Marco Caminati, Giovanni Passalacqua
Frontiers in Allergy|June 30, 2022
COVID-19, Eosinophils, and Biologicals for Severe AsthmaCarlo Lombardi, Diego Bagnasco, Giovanni Passalacqua
Current Opinion in Allergy and Clinical Immunology|June 27, 2020
Biological agents for severe asthma: the evolution of the at-home self-injection approachCarlo Lombardi, Diego Bagnasco, Giovanni Passalacqua
Expert Review of Respiratory Medicine|September 10, 2019
Comparing a fixed combination of budesonide/formoterol with other inhaled corticosteroid plus long-acting beta-agonist combinations in patients with chronic obstructive pulmonary disease: a reviewPaolo Solidoro, Filippo Patrucco, Diego Bagnasco
Current Opinion in Allergy and Clinical Immunology|December 2, 2025
Modifying the course of asthma: mechanisms and strategies for clinical remissionBenedetta Bondi, Diego Bagnasco, Fulvio Braido
Current Opinion in Allergy and Clinical Immunology|November 9, 2018
Strategies to reduce corticosteroid-related adverse events in asthmaEnrico Heffler, Diego Bagnasco, Giorgio W Canonica
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Current Opinion in Allergy and Clinical Immunology|June 15, 2021
Real-life studies in allergen immunotherapyGiovanni Passalacqua, Diego Bagnasco
Biomedicines|February 27, 2026
New Insights in Respiratory DiseasesDiego Bagnasco, Benedetta Bondi
Frontiers in Immunology|January 16, 2023
Editorial: Innate immunity and severe asthma: From microbiome to target therapyDiego Bagnasco, Marco Caminati
Allergy|July 19, 2019
Severe asthma, biologicals, and auto-injection: Yes, no, may be!Carlo Lombardi, Giovanni Passalacqua, Diego Bagnasco
Current Opinion in Allergy and Clinical Immunology|November 6, 2019
Biologicals for severe asthma: what we can learn from real-life experiences?Diego Bagnasco, Marco Caminati, Giovanni Passalacqua
Frontiers in Allergy|June 30, 2022
COVID-19, Eosinophils, and Biologicals for Severe AsthmaCarlo Lombardi, Diego Bagnasco, Giovanni Passalacqua
Current Opinion in Allergy and Clinical Immunology|June 27, 2020
Biological agents for severe asthma: the evolution of the at-home self-injection approachCarlo Lombardi, Diego Bagnasco, Giovanni Passalacqua
Expert Review of Respiratory Medicine|September 10, 2019
Comparing a fixed combination of budesonide/formoterol with other inhaled corticosteroid plus long-acting beta-agonist combinations in patients with chronic obstructive pulmonary disease: a reviewPaolo Solidoro, Filippo Patrucco, Diego Bagnasco
Current Opinion in Allergy and Clinical Immunology|December 2, 2025
Modifying the course of asthma: mechanisms and strategies for clinical remissionBenedetta Bondi, Diego Bagnasco, Fulvio Braido
Current Opinion in Allergy and Clinical Immunology|November 9, 2018
Strategies to reduce corticosteroid-related adverse events in asthmaEnrico Heffler, Diego Bagnasco, Giorgio W Canonica
Pageof 13